Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0646
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia ; volume:32 ; number:3 ; day:20 ; month:12 ; year:2013 ; pages:489-499 ; date:6.2014
Investigational new drugs ; 32, Heft 3 (20.12.2013), 489-499, 6.2014
- Creator
-
Kelly, Kevin R.
Shea, Thomas C.
Goy, André
Berdeja, Jesus G.
Reeder, Craig B.
McDonagh, Kevin T.
Zhou, Xiaofei
Danaee, Hadi
Liu, Hua
Ecsedy, Jeffrey A.
Niu, Huifeng
Benaim, Ely
Padmanabhan Iyer, Swaminathan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10637-013-0050-9
- URN
-
urn:nbn:de:101:1-2019080220211072936077
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kelly, Kevin R.
- Shea, Thomas C.
- Goy, André
- Berdeja, Jesus G.
- Reeder, Craig B.
- McDonagh, Kevin T.
- Zhou, Xiaofei
- Danaee, Hadi
- Liu, Hua
- Ecsedy, Jeffrey A.
- Niu, Huifeng
- Benaim, Ely
- Padmanabhan Iyer, Swaminathan
- SpringerLink (Online service)